75 related articles for article (PubMed ID: 9399640)
1. Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast differentiation.
Weyman CM; Wolfman A
Oncogene; 1997 Nov; 15(21):2521-8. PubMed ID: 9399640
[TBL] [Abstract][Full Text] [Related]
2. Active Ras-induced effects on skeletal myoblast differentiation and apoptosis are independent of constitutive PI3-kinase activity.
Karasarides M; Dee K; Schulman D; Wolfman A; Weyman CM
Cell Biol Int; 2006 Apr; 30(4):308-18. PubMed ID: 16503174
[TBL] [Abstract][Full Text] [Related]
3. Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras.
Weyman CM; Ramocki MB; Taparowsky EJ; Wolfman A
Oncogene; 1997 Feb; 14(6):697-704. PubMed ID: 9038377
[TBL] [Abstract][Full Text] [Related]
4. Phorbol ester-induced production of cytostatic factors by normal and oncogenic Ha-ras-transformed human breast cell lines.
Guo M; Reiners JJ
Carcinogenesis; 2000 Jul; 21(7):1303-12. PubMed ID: 10874007
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
Layne MD; Farmer SR
Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene.
Konieczny SF; Drobes BL; Menke SL; Taparowsky EJ
Oncogene; 1989 Apr; 4(4):473-81. PubMed ID: 2654809
[TBL] [Abstract][Full Text] [Related]
7. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
Zhang KX; Ward KR; Schrader JW
Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional down-regulation of myogenin expression is associated with v-ras-induced block of differentiation in unestablished quail muscle cells.
Russo S; Tatò F; Grossi M
Oncogene; 1997 Jan; 14(1):63-73. PubMed ID: 9010233
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.
Foulstone EJ; Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906
[TBL] [Abstract][Full Text] [Related]
10. Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway.
Conejo R; de Alvaro C; Benito M; Cuadrado A; Lorenzo M
Oncogene; 2002 May; 21(23):3739-53. PubMed ID: 12032842
[TBL] [Abstract][Full Text] [Related]
11. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts.
Foulstone EJ; Savage PB; Crown AL; Holly JM; Stewart CE
J Cell Physiol; 2003 Apr; 195(1):70-9. PubMed ID: 12599210
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor autocrine signaling in RIE-1 cells transformed by the Ras oncogene enhances radiation resistance.
Grana TM; Sartor CI; Cox AD
Cancer Res; 2003 Nov; 63(22):7807-14. PubMed ID: 14633707
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts.
Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2000 Jun; 183(3):330-7. PubMed ID: 10797307
[TBL] [Abstract][Full Text] [Related]
14. Induction of transforming growth factor beta 1 by insulin-like growth factor-1 in dermal fibroblasts.
Ghahary A; Shen Q; Shen YJ; Scott PG; Tredget EE
J Cell Physiol; 1998 Mar; 174(3):301-9. PubMed ID: 9462692
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells.
Dong F; Wu HB; Hong J; Rechler MM
J Cell Physiol; 2002 Jan; 190(1):63-73. PubMed ID: 11807812
[TBL] [Abstract][Full Text] [Related]
16. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
Fenton RG; Hixon JA; Wright PW; Brooks AD; Sayers TJ
Cancer Res; 1998 Aug; 58(15):3391-400. PubMed ID: 9699671
[TBL] [Abstract][Full Text] [Related]
18. Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha.
Foulstone EJ; Huser C; Crown AL; Holly JM; Stewart CE
Exp Cell Res; 2004 Mar; 294(1):223-35. PubMed ID: 14980516
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
Lo J; Hurta RA
Biochem Cell Biol; 2000; 78(4):527-35. PubMed ID: 11012093
[TBL] [Abstract][Full Text] [Related]
20. Developmental regulation of intermediate filament and actin mRNAs during myogenesis is disrupted by oncogenic ras genes.
Olson EN; Capetanaki YG
Oncogene; 1989 Jul; 4(7):907-13. PubMed ID: 2666910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
